 |
|
Carbidopa in Parkinson Disease and in Nausea and Vomiting of Levodopa
Charles H. Markham, MD;
Shirley G. Diamond;
Leo J. Treciokas, MD
Arch Neurol. 1974;31(2):128-133.
Abstract
Twenty Parkinson disease patients with long-standing nausea and vomiting and with major and stable improvement in parkinsonian symptoms participated in a double-blind trial of carbidopa, a peripherally acting dopa decarboxylase inhibitor. Initially, half the patients, selected randomly, received carbidopa plus 20% of their previous levodopa dosage in fixed combination tablets containing levodopa:carbidopa in a 10:1 ratio. The other half received levodopa alone. Later, all patients received the combination tablets.
Throughout the study the only meaningful side effect was choreoathetosis. This occurred in four patients who had had this previously while taking levodopa alone.
All patients improved remarkably in nausea and vomiting, which persisted for the duration of the study. Most also showed mild to moderate improvement in the parkinsonian signs, symptoms, and functional states, as measured on three separate grading systems.
Author Affiliations
Los Angeles
From the Department of Neurology, UCLA School of Medicine, Los Angeles
Footnotes
Accepted for publication Dec 24, 1973.
Reprint requests to Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90024 (Dr. Markham).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Sinemet and the Treatment of Parkinsonism
BOSHES
ANN INTERN MED 1981;94:364-370.
ABSTRACT
Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Tourtellotte et al.
Arch Neurol 1980;37:723-726.
ABSTRACT
Increased Dosage of Carbidopa in Patients With Parkinson's Disease Receiving Low Doses of Levodopa: A Pilot Study
Hoehn
Arch Neurol 1980;37:146-149.
ABSTRACT
|
